According to the Midwest Healthcare Venture Investment Report, life-science companies in the Cleveland area had attracted no less than US$80 million in venture capital in the first two quarters of this year. The Midwest Healthcare Venture Investment Report was released by BioEnterprise.
The region's performance, although impressive, actually dipped significantly from the same time period in 2012. The first six months of 2012 saw healthcare investors committing US$104 million worth of financial aid into Greater Cleveland-area entrepreneurs and start up firms.
Analysts, however, consider last year's numbers to be a one-off anomaly. They stated that the 2013 investment figures towards the Midwest state will still help solidify the region's reputation as a national player in advanced healthcare innovation.
"We're ahead of every year for the last five years, except for last year, which was exceptional. We've sort of established a consistency, year to year, of getting national investors to put their money here," BioEnterprise president Aram Nerpouni said. BioEnterprise is a healthcare business developer based in Cleveland.
Join the Conversation